|Judith Hoyer Lecture on Epilepsy|
|Anticonvulsant Screening Program (ASP) |
NIH RePORTER is an electronic tool that allows users to search a repository of NIH-funded research projects and access publications and patents resulting from NIH funding.
|Brandy Fureman, Ph.D.|
Program Director, Channels Synapses & Circuits Cluster
Jaideep Kapur, M.D., Ph.D.
“Now’s the Time: Exciting Opportunities in Epilepsy Research,”
November 30, 2012 -- 66th annual American Epilepsy Society meeting, San Diego
Dr. Jaideep Kapur is the Eugene Meyer III Professor of Neuroscience and Professor of Neurology at the University of Virginia Medical School, where he also holds the Harrison Distinguished Teaching Chair in neurology. Dr. Kapur’s talk delved into treatment and outcome disparities in epilepsy management. He also discussed the Affordable Care Act’s potential impact on people with epilepsy, the importance of comparative effectiveness trials, and new models of individualized care using pharmacogenetics and biomarkers.
Steven Schachter, M.D.
“Psychosocial Aspects of Epilepsy: State of the Art”
December 20, 2011 -- 65 th annual American Epilepsy Society meeting, Baltimore
Dr. Steven Schachter is Professor of Neuroscience at Harvard University and Chief Academic Officer at the Center for Integration of Medicine & Innovative Technology. Dr. Schachter emphasized looking into the day-to-day aspects of epilepsy, such as the experience of seizures from the point of view of someone having a seizure and how artwork and music can inspire research because they underscore the perspectives of people affected by epilepsy. An accompanying slideshow of artwork by people with epilepsy demonstrated the importance of taking a holistic approach.
Dennis D. Spencer, M.D.
“Clinical Research in Epilepsy: Lost in Translation”
December 4, 2010 -- 64th annual American Epilepsy Society meeting, San Antonio
Dr. Dennis D. Spencer is the Harvey and Kate Cushing Professor and Chair of the Department of Neurosurgery at the Yale University School of Medicine. Dr. Spencer reviewed the development of the NINDS-sponsored antiepileptic drug development program and Phase III clinical trials. He also described challenges facing investigators seeking to advance future translational and clinical research on the epilepsies.
John W. Swann, Ph.D.
“Battling Epilepsy with Models and Molecules”
December 5, 2009 -- 63rd annual American Epilepsy Society meeting, Boston
Dr. John W. Swann is Professor of Pediatrics, Neuroscience and Translational Biology and Molecular Medicine at Baylor College of Medicine. He described the breadth of epilepsy research, from basic and translational studies to clinical trials. In addition, he pointed to insights from animal models that may hold promise for treatment development.
Gregory L. Holmes, M.D.
“Epilepsy in Children: Listening to Mothers”
December 5, 2008 -- 62nd annual American Epilepsy Society meeting, Seattle
Dr. Gregory L. Holmes, Professor of Neurology and Pediatrics and Chair of the Department of Neurology at Dartmouth Medical School, reviewed research that addressed an important question often raised by mothers: What are these seizures doing to my child's brain? It is now well recognized that the brains of children differ considerably from adults in both seizure susceptibility and consequences.
Joan K. Austin, DNS, RN, FAAN
“Epilepsy Comorbidities: Lennox and Lessons Learned”
November 30, 2007 -- 61st annual American Epilepsy Society meeting, Philadelphia
Dr. Joan K. Austin is Distinguished Professor and Sally Reahard Chair in the School of Nursing at Indiana University, Indianapolis. In her lecture, she presented an overview of the comorbidities associated with epilepsy, including cognitive and memory dysfunction, depression, anxiety, and attention disorders. She reviewed early descriptions of mental health and cognitive problems affecting people with epilepsy that were written by key historical figures, and she discussed important lessons learned from research as well as the challenges ahead.
Daniel H. Lowenstein, M.D.
“Pathways to Discovery in Epilepsy Research: Rethinking the Quest for Cures”
December 1, 2006 -- 60th annual American Epilepsy Society meeting, San Diego
Dr. Daniel H. Lowenstein is Professor and Vice Chair in the Department of Neurology at the University of California, San Francisco. He presented an overview of the limitations of current therapies, reviewed research accomplishments in the past 100 years, and emphasized the importance of large, collaborative projects and advancing technology to solve the research questions that remain.
Jeffrey L. Noebels, M.D., Ph.D.
“New Tools to Cure Epilepsy: Genes, Pixels, Patterns and Prevention”
December 2, 2005 -- 59th annual American Epilepsy Society meeting, Washington, D.C.
Dr. Jeffrey L. Noebels, M.D., Ph.D., is Professor of Molecular and Human Genetics at Baylor College of Medicine. His lecture focused on advances in science and technology that are beginning to change the way we think about why people develop epilepsy, when the precise causes can be pinpointed in the brain, and how we can more accurately personalize treatment for every patient.
Thomas P. Sutula, M.D., Ph.D.
“Epilepsy After the Decade of the Brain: Misunderstandings, Challenges, and Opportunities”
December 3, 2004 -- 58th annual American Epilepsy Society meeting, New Orleans
Thomas P. Sutula, M.D. Ph.D., is Chair of the Department of Neurology at the University of Wisconsin School of Medicine and Public Health. His presentation explored some of the reasons why epilepsy is challenging for healthcare professionals and scientists and how it is often misunderstood by the public.
Jerome Engel, Jr., M.D., Ph.D.
“New Attitudes and New Approaches to Treating Epilepsy”
November 12, 2002 -- Library of Congress, Washington, D.C.
Dr. Jerome Engel, Jr., is Director of the Seizure Disorder Center at the University of California, Los Angeles. His lecture provided an overview of treatments for epilepsy, with a particular focus on early surgical treatment of epilepsy.
Last Modified October 20, 2015